MedTrace Logo

Quality of Care in AS IMPULSE Study

NCT02241447 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2173

Last updated 2020-03-04

No results posted yet for this study

Summary

The purpose of this study is to narrow the gap between patients being diagnosed with severe aortic stenosis and those being appropriately monitored and treated. For this purpose a prospective survey of current practice (3 months) will be conducted followed by a six month period of intervention during which a variety of quality improvements measures will be implemented. There will then be a 3 month follow-up period during which the legacy of this initiative will be monitored during which no intervention will be carried out.

Conditions

  • Aortic Valve Stenosis

Sponsors & Collaborators

  • Edwards Lifesciences

    collaborator INDUSTRY

  • Institut für Pharmakologie und Präventive Medizin

    lead NETWORK

Principal Investigators

  • Richard Steeds, MD · Queen Elizabeth Hospital, Birmingham, UK

  • Norbert Frey, MD · Department of Cardiology and Angiology, University of Kiel, Germany

  • Davia Messika-Zeitoun, MD · Hôpital Bichat, Paris FR

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-08
Primary Completion
2018-05-15
Completion
2018-05-31

Countries

  • Austria
  • Czechia
  • France
  • Germany
  • Italy
  • Netherlands
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02241447 on ClinicalTrials.gov